THE BLANDFORD GROUP PRACTICE
BLANDFORD GROUP PRACTICE, WHITECLIFF MILL STREET, BLANDFORD FORUM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 10 | 80.0% | |
| HF 4 | 2011 | 8 | 12 | 66.7% | |
| HF 4 | 2012 | 11 | 14 | 78.6% | |
| HF 4 | 2013 | 15 | 16 | 93.8% | |
| HF004 | 2014 | 5 | 5 | 100.0% | |
| HF004 | 2015 | 11 | 11 | 100.0% | |
| HF004 | 2016 | 13 | 13 | 100.0% | |
| HF004 | 2017 | 12 | 12 | 100.0% | |
| HF004 | 2018 | 13 | 13 | 100.0% | |
| HF004 | 2019 | 19 | 19 | 100.0% | |
| HF004 | 2020 | 56 | 57 | 98.2% | |
| HF006 | 2021 | 69 | 71 | 97.2% | |
| HF006 | 2022 | 89 | 91 | 97.8% | |
| HF006 | 2023 | 173 | 188 | 92.0% |
